And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

BBI Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 4.53%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Brickell Biotech Insider Trading History Chart

Brickell Biotech Share Price & Price History

^$0.00

+0.30 (1.20%)

As of 09/8/2022 12:59 AM ET

World’s biggest multibillionaire investor is buying THIS by the ton [picture]

From Stansberry Research | Ad

Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.

Click here to find out what to do.

Brickell Biotech Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/26/2021	Reginald L Hardy	Chairman	Buy	100,000	$0.67	$67,000.00
7/23/2021	David R. Mcavoy	General Counsel	Buy	18,124	$0.67	$12,143.08	128,879
7/23/2021	Reginald L. Hardy	Chairman	Buy	100,000	$0.66	$66,000.00	348,411
5/18/2021	Deepak Chadha	Insider	Buy	2,700	$0.82	$2,214.00	65,667
5/17/2021	Andrew D. Sklawer	COO	Buy	15,375	$0.80	$12,300.00	124,625
5/17/2021	David R. McAvoy	General Counsel	Buy	18,622	$0.80	$14,897.60	110,755

The "Smart Money" Is Ready for May 1st Are You?

From Stansberry Research | Ad

Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company.

One Former Wall St. Trader Explains Why…

SEC Filings (Institutional Ownership Changes) for Brickell Biotech (NASDAQ:BBI)

Institutional Buying and Selling by Quarter

Brickell Biotech Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2021	Telemetry Investments L.L.C.	699,338	$0.50M	0.7%	+14.6%	0.608%
11/15/2021	GSA Capital Partners LLP	248,693	$0.18M	0.0%	N/A	0.216%
11/12/2021	Renaissance Technologies LLC	1,377,804	$0.99M	0.0%	-9.3%	1.198%
11/9/2021	BlackRock Inc.	63,544	$46K	0.0%	+69.2%	0.055%
11/5/2021	Smith Salley & Associates	44,380	$32K	0.0%	-88.3%	0.050%
8/16/2021	Telemetry Investments L.L.C.	609,993	$0.58M	0.8%	+18.9%	0.718%
8/16/2021	State Street Corp	60,847	$58K	0.0%	N/A	0.072%
8/13/2021	Renaissance Technologies LLC	1,519,027	$1.45M	0.0%	+41.1%	1.789%
8/13/2021	Geode Capital Management LLC	563,312	$0.54M	0.0%	+5.7%	0.663%
8/13/2021	Vanguard Group Inc.	2,601,358	$2.48M	0.0%	+49.7%	3.063%
8/9/2021	Smith Salley & Associates	379,167	$0.36M	0.0%	+754.4%	0.446%
5/19/2021	Virtu Financial LLC	65,605	$72K	0.0%	+242.0%	0.098%
5/17/2021	HRT Financial LP	27,407	$29K	0.0%	N/A	0.041%
5/17/2021	Thrivent Financial for Lutherans	52,134	$57K	0.0%	+139.6%	0.078%
5/13/2021	Renaissance Technologies LLC	1,076,537	$1.17M	0.0%	+22.6%	1.608%
5/13/2021	Bank of New York Mellon Corp	60,367	$66K	0.0%	N/A	0.090%
5/12/2021	Geode Capital Management LLC	533,127	$0.58M	0.0%	+166.6%	0.797%
5/7/2021	Fifth Third Bancorp	25,000	$27K	0.0%	N/A	0.037%
4/30/2021	Smith Salley & Associates	44,380	$48K	0.0%	+271.5%	0.066%
2/16/2021	Squarepoint Ops LLC	83,783	$65K	0.0%	N/A	0.157%
2/10/2021	Renaissance Technologies LLC	877,986	$0.69M	0.0%	+42.0%	1.641%
8/12/2020	Goldman Sachs Group Inc.	74,277	$74K	0.0%	N/A	0.304%

Data available starting January 2016

Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammatory diseases; and BBI-10, a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases, as well as next-generation kinase inhibitors. It has license and collaboration agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. The company was founded in 2009 and is headquartered in Boulder, Colorado.

Today's Range

Now: N/A

50 Day Range

MA: $0.86

$0.77

$0.93

52 Week Range

Now: N/A

Volume

31,300 shs

Average Volume

206,730 shs

Market Capitalization

$6.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.02

He Is Giving Away Bitcoin

From Crypto Swap Profits | Ad

>> Register right here